SANOFISANOFISANOFI

SANOFI

No trades
See on Supercharts

Key facts today


Intron Health upgraded its rating on Sanofi from hold to buy and increased its price target from 100 euros to 125 euros.
Sanofi is in talks with Adocia for M1Pram, a combo insulin and amylin treatment for obesity in Type 1 Diabetes. A Phase 2b trial with 140 patients is planned, pending funding.
In April 2023, Sanofi announced a settlement for approximately 4,000 lawsuits concerning its former heartburn drug Zantac, which has been implicated in claims alleging a link to cancer.
Analyze the impactAnalyze the impact
Market capitalization
‪4.65 T‬THB
158.16THB
‪197.93 B‬THB
‪1.46 T‬THB
‪1.15 B‬
Beta (1Y)
−0.03

About SANOFI


CEO
Paul Hudson
Headquarters
Paris
Website
Founded
1994
ISIN
TH0150122602
FIGI
BBG01Q6L1ZG2
Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes and cardiovascular, established prescription products and generics, and research, development, and production activities. The Consumer Healthcare segment includes the commercial operations for its Consumer Healthcare products. The Vaccines segment consists commercial operations of Sanofi Pasteur. The company was founded in 1973 and is headquartered in Paris, France.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:

See all ideas 

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
US801060AD6
SANOFI SA 18/28
Yield to maturity
4.49%
Maturity date
Jun 19, 2028
FR1332437
SANOFI 18/38 MTN
Yield to maturity
3.30%
Maturity date
Mar 21, 2038
FR1340985
SANOFI 19/34 MTN
Yield to maturity
3.04%
Maturity date
Mar 21, 2034
FR1332435
SANOFI 18/30 MTN
Yield to maturity
2.81%
Maturity date
Mar 21, 2030
FR1340984
SANOFI 19/29 MTN
Yield to maturity
2.75%
Maturity date
Mar 21, 2029
FR1350511
SANOFI 20/30 MTN
Yield to maturity
2.75%
Maturity date
Apr 1, 2030
FR14009KQ
SANOFI 22/29 MTN
Yield to maturity
2.69%
Maturity date
Apr 6, 2029
FR1350510
SANOFI 20/25 MTN
Yield to maturity
2.68%
Maturity date
Apr 1, 2025
FR1332434
SANOFI 18/26 MTN
Yield to maturity
2.61%
Maturity date
Mar 21, 2026
FR14009KS
SANOFI 22/25 MTN
Yield to maturity
2.56%
Maturity date
Apr 6, 2025
FR1320163
SANOFI 16/27 MTN
Yield to maturity
2.56%
Maturity date
Jan 13, 2027

Explore more bonds